URGN
|
UroGen Pharma Ltd.
|
0.01%
|
US
|
NASDAQ
|
TSHA
|
Taysha Gene Therapies, Inc.
|
0.01%
|
US
|
NASDAQ
|
TKNO
|
Alpha Teknova, Inc.
|
0.01%
|
US
|
NASDAQ
|
TCRR
|
TCR2 Therapeutics Inc.
|
0.01%
|
US
|
NASDAQ
|
TALS
|
Talaris Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
SURF
|
Surface Oncology, Inc.
|
0.01%
|
US
|
NASDAQ
|
STTK
|
Shattuck Labs, Inc.
|
0.01%
|
US
|
NASDAQ
|
SPPI
|
Spectrum Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
SMMT
|
Summit Therapeutics plc
|
0.01%
|
US
|
NASDAQ
|
SLDB
|
Solid Biosciences Inc.
|
0.01%
|
US
|
NASDAQ
|
SESN
|
Sesen Bio, Inc.
|
0.01%
|
US
|
NASDAQ
|
RUBY
|
Rubius Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
RPID
|
Rapid Micro Biosystems, Inc
|
0.01%
|
US
|
NASDAQ
|
RAIN
|
Rain Therapeutics Inc.
|
0.01%
|
US
|
NASDAQ
|
PSTX
|
Poseida Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
PSNL
|
Personalis, Inc.
|
0.01%
|
US
|
NASDAQ
|
PRTK
|
Paratek Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
PRAX
|
Praxis Precision Medicines, Inc.
|
0.01%
|
US
|
NASDAQ
|
PBYI
|
Puma Biotechnology Inc
|
0.01%
|
US
|
NASDAQ
|
PASG
|
Passage Bio, Inc.
|
0.01%
|
US
|
NASDAQ
|